Cantila, Felecidad L.
HRN: 25-78-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/20/2024
09/28/2024
IV
4.5g
Q8
Complicated UTI, Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes